Osteoporosis Disease Management Demonstration Project (0000-037)

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoporosis Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases

Age range

65 year–89 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Members of the Henry Ford Health System

Exclusion criteria

Individuals who are not members of the Henry Ford Health System

Treatment and study plan

Disease Management Assessment

Behavioral

Primary outcomes

Bone mineral density (BMD) testing rates

Secondary outcomes

Osteoporosis medication treatment rates

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Official study title

Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project

Important dates

Study start: 2003
Primary completion: 2004
Study completion: 2004
First posted: Aug 31, 2005
Registry last updated: Apr 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed